chemokin
report
play
import
role
progress
mani
malign
breast
cancer
papillari
thyroid
carcinoma
role
colorect
carcinoma
crc
remain
establish
purpos
studi
investig
express
pattern
signific
crc
progress
method
colorect
carcinoma
specimen
match
adjac
normal
colorect
mucosa
specimen
collect
express
clinic
sampl
examin
immunostain
effect
colorect
carcinoma
cell
prolifer
measur
mtt
assay
brdu
incorpor
assay
coloni
format
assay
impact
migrat
invas
colorect
carcinoma
cell
determin
transwel
assay
matrigel
invas
assay
respect
result
express
significantli
upregul
tumor
tissu
compar
adjac
nontumor
mucosa
tissu
p
tumor
express
level
significantli
correl
tnm
tumornodemetastasi
stage
histodifferenti
tumor
size
multivari
cox
regress
analysi
high
express
tumor
specimen
n
stage
iii
patient
associ
increas
risk
diseas
recurr
risk
ratio
ci
p
elev
express
tumor
specimen
n
stage
iiiiv
patient
correl
wors
overal
surviv
risk
ratio
ci
p
function
studi
demonstr
enforc
express
colorect
carcinoma
cell
result
aggress
phenotyp
contrast
knockdown
express
could
mitig
prolif
migratori
invas
potenti
colorect
carcinoma
cell
conclus
taken
togeth
might
potenti
novel
prognost
factor
predict
diseas
recurr
overal
surviv
could
potenti
target
postop
adjuv
therapi
crc
patient
undertr
patient
destin
relaps
overtr
patient
could
cure
surgeri
alon
thu
new
biomark
pivot
tumor
biolog
urgent
need
improv
prognosi
adjuv
treatment
regimen
chemokin
famili
small
kda
secret
protein
orchestr
leukocyt
traffick
implic
tumor
develop
progress
exert
cellular
effect
specif
activ
correspond
transmembran
g
proteincoupl
receptor
chemokin
classifi
c
cc
cxc
cx
c
famili
base
variat
structur
motif
conserv
ntermin
cystein
residu
approxim
chemokin
chemokin
receptor
identifi
chemokin
could
promot
invas
cancer
cell
trigger
integrin
cluster
enhanc
adher
extracellular
matrix
via
receptor
furthermor
chemokin
chemokin
receptor
could
also
serv
prognost
factor
cancer
outcom
origin
identifi
brak
bmac
chemokin
yet
unknown
function
molecul
first
identifi
differenti
display
use
normal
epitheli
cell
head
neck
squamou
carcinoma
cell
shown
express
mani
normal
tissu
variou
tumor
epitheli
origin
heterogen
express
level
uniqu
member
chemokin
famili
receptor
yet
identifi
role
molecul
tumor
progress
controversi
although
role
tumor
suppressor
seem
well
establish
recent
studi
suggest
might
actual
promot
tumor
progress
exampl
report
upregul
pancreat
cancer
tissu
compar
chronic
pancreat
normal
pancrea
also
document
transcript
markedli
higher
papillari
thyroid
carcinoma
adjac
noncancer
tissu
posit
correl
lymph
node
metastasi
also
act
multimod
stimul
prostat
stomach
tumor
growth
find
necessit
reevalu
function
epitheli
tumor
till
littl
data
suggest
associ
colorect
carcinoma
studi
therefor
design
investig
express
clinic
signific
colorect
cancer
result
show
elev
express
primari
colorect
cancer
associ
poor
diseasefre
surviv
overal
surviv
indic
might
use
potenti
prognost
marker
crc
patient
cell
cultur
rko
lovo
colorect
cancer
cell
line
purchas
american
type
cultur
collect
atcc
rockvil
md
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
contain
heatinactiv
fetal
calf
serum
hyclon
logan
ut
penicillin
ul
streptomycin
mgl
humidifi
chamber
contain
vv
co
air
clone
cdna
isol
total
rna
cell
line
first
strand
cdna
revers
transcrib
total
rna
final
volum
use
revers
transcriptas
random
hexam
exscript
reagent
kit
takara
dalian
china
accord
manufactur
instruct
primer
design
use
primer
premier
softwar
primer
use
forward
cgg
gat
cca
tgt
ccc
tgc
tcc
cac
revers
ccc
tcg
agc
tat
tct
tcg
tag
acc
ctg
cgc
bp
product
fragment
pcr
perform
rtaq
takara
dna
thermal
cycler
biorad
accord
standard
protocol
follow
initi
denatur
min
follow
cycl
denatur
anneal
elong
last
cycl
termin
elong
step
min
ad
thereaft
sampl
kept
pcr
product
run
agaros
gel
stain
sybr
gold
molecular
probe
eugen
analyz
uv
light
construct
eukaryot
express
vector
cdna
clone
plasmid
use
eukaryot
ta
express
kit
invitrogen
life
technolog
grand
island
ny
accord
manufactur
instruct
human
colorect
cell
line
transfect
human
express
vector
use
lipofectamin
invitrogen
life
technolog
grand
island
ny
accord
supplier
instruct
next
transfect
cell
split
treat
invitrogen
life
technolog
grand
island
ny
clone
obtain
cell
stabli
transfect
empti
vector
use
mock
control
valid
differ
express
among
colorect
cell
line
perform
semiquantit
rtpcr
gene
transcript
gapdh
analyz
twostep
revers
transcriptionpcr
shrna
express
vector
target
scrambl
sequenceexpress
vecotr
neg
control
shnc
synthes
follow
publish
literatur
insert
sequenc
shrna
gca
cca
agc
gct
tca
tca
act
gtg
aag
cca
cag
atg
ggt
tga
tga
agc
gct
tgg
scrambl
control
shrna
gcc
ata
cgc
gac
ata
acc
tct
gtg
aag
cca
cag
atg
gga
ggt
tat
gtc
gcg
tat
underlin
nucleotid
indic
hairpin
loop
sequenc
cell
transfect
vector
use
lipofectamin
cell
treat
lipofectamin
alon
use
mock
control
prolifer
motil
assay
cell
transfect
vector
h
use
express
analys
cell
harvest
h
post
transfect
protein
extract
ripa
buffer
mm
trisbas
mm
edta
mm
nacl
sd
sodium
deoxychol
mm
phenylmethylsulfonyl
fluorid
quantifi
use
dc
protein
assay
kit
biorad
usa
sampl
separ
sdspage
transfer
pvdf
membran
amersham
bioscienc
membran
block
overnight
pb
contain
tween
skim
milk
subsequ
probe
use
follow
primari
antibodi
dilut
proteintech
blot
incub
respect
primari
antibodi
h
room
temperatur
wash
time
tb
tween
subsequ
blot
incub
secondari
antibodi
dilut
santa
cruz
biotechnolog
conjug
horseradish
peroxidas
h
room
temperatur
target
protein
detect
enhanc
chemiluminesc
reagent
amersham
bioscienc
piscataway
nj
previous
describ
use
intern
control
vitro
prolifer
assay
deoxyuridin
brdu
incorpor
assay
perform
previous
describ
cell
seed
cultur
plate
densiti
grown
preconflu
treatment
brdu
mm
roch
appli
scienc
indianapoli
ad
well
incub
h
antibrdu
antibodi
zhongshan
biothechnolog
zhongshan
china
appropri
fluorescein
isothiocyanatelabel
secondari
antibodi
use
stain
visual
use
confoc
microscop
leica
heidelb
germani
cell
prolifer
determin
count
number
brduposit
cell
eight
altern
area
bromid
mtt
assay
perform
describ
previous
evalu
cell
growth
soft
agar
cell
cellswel
resuspend
dmem
contain
fb
agaros
layer
top
agaros
dmem
plate
coloni
format
assay
cell
cellswel
resuspend
dmem
fb
peprotech
ngml
plate
cultur
maintain
day
plate
stain
crystal
violet
experi
done
triplic
cell
migrat
assay
perform
transwel
chamber
corn
ny
cell
serumfre
medium
cell
per
well
ad
upper
chamber
h
number
cell
migrat
membran
lower
chamber
count
invas
assay
matrigel
bd
ad
transwel
membran
chamber
incub
h
seed
cell
cell
migrat
lower
chamber
count
h
previous
describ
primari
colorect
tumor
correspond
adjac
normal
colorect
mucosa
subject
collect
patient
underw
surgic
resect
sichuan
provinci
peopl
hospit
chengdu
china
primari
tumor
stage
accord
tumornodemetastasi
tnm
classif
system
intern
union
cancer
tumor
differenti
grade
accord
edmondson
steiner
grade
experienc
pathologist
clinicopatholog
patient
inform
extract
clinic
note
summari
detail
colorect
cancer
demograph
list
tabl
inform
consent
tissu
procur
obtain
patient
prior
analysi
project
approv
institut
ethic
committe
sichuan
univers
tissu
formalinfix
paraffinembed
serial
thick
section
taken
immunohistochemistri
analysi
use
dako
envis
system
dako
cytom
gmbh
hamburg
germani
denmark
accord
manufactur
instruct
briefli
paraffin
section
deparaffin
rehydr
incub
h
min
dark
room
temperatur
block
endogen
peroxidas
activ
antigenretriev
citrat
buffer
ph
use
autoclav
steril
method
subsequ
section
preincub
normal
fetal
calf
goat
serum
dilut
pb
ph
min
follow
incub
overnight
primari
antibodi
rabbit
dilut
proteintech
rabbit
dilut
abcam
rabbit
dilut
abcam
rins
fresh
pb
slide
incub
horseradish
peroxidaselink
goat
antirabbit
antibodi
min
follow
stain
dab
substrat
solut
dako
cytom
gmbh
counterstain
mayer
hematoxylin
nonimmun
rabbit
igg
dilut
primari
antibodi
use
neg
control
cell
visibl
brown
particl
cytoplasm
regard
posit
section
evalu
two
senior
pathologist
yx
dd
blind
patient
outcom
clinicopatholog
find
immunohistochem
stain
evalu
base
intens
weak
intens
immunostain
densiti
invers
posit
tumor
cell
final
score
sampl
multipli
intens
densiti
tumor
final
determin
invers
score
low
express
score
high
express
score
evalu
agre
specimen
reevalu
classifi
accord
assess
given
frequent
observ
analysi
perform
spss
window
spss
inc
qualit
variabl
compar
use
pearson
test
fisher
exact
test
quantit
variabl
analyz
test
spearman
test
nonparametr
variabl
use
evalu
correl
clinic
factor
express
surviv
curv
colorect
cancer
patient
high
low
express
level
construct
use
kaplanmei
analysi
univari
analysi
clinic
factor
includ
age
sex
tnm
stage
tumor
invas
lymph
node
metastas
histodifferenti
locat
tumor
size
assess
logrank
test
multivari
analysi
diseasefre
surviv
overal
surviv
perform
cox
proport
hazard
regress
model
use
forward
stepwis
method
clinic
prognost
factor
adjust
result
consid
statist
signific
p
valu
less
investig
potenti
clinic
role
chemokin
colorect
cancer
immunohistochemistri
stain
perform
colorect
cancer
specimen
match
adjac
normal
colorect
mucosa
specimen
antibodi
specif
first
confirm
addit
file
figur
strong
stain
mainli
observ
cytoplasm
tumor
cell
partial
normal
mucosa
figur
stain
observ
normal
colorect
mucosa
sampl
primari
crc
sampl
express
markedli
upregul
colorect
tumor
tissu
compar
normal
colorect
mucosa
p
figur
c
high
immunoreact
also
found
colorect
cancer
tissu
compar
adjac
non
cancer
tissu
use
anoth
antibodi
recogn
may
rule
possibl
nonspecif
stain
addit
file
figur
stroma
cell
although
sporad
posit
stain
cell
also
observ
analys
suggest
upregul
might
involv
colorect
cancer
initi
progress
next
analyz
relev
express
tumor
tissu
clinicopatholog
factor
paramet
includ
analysi
sex
male
femal
age
tnm
stage
stage
ii
iii
iv
tumor
invas
histodifferenti
well
moder
poorli
differenti
lymph
node
metastasi
tumor
size
locat
colon
rectum
found
level
express
posit
associ
tnm
stage
p
figur
c
tabl
revers
associ
histodifferenti
p
figur
tabl
crc
case
stage
submucosa
invas
stage
ii
subseros
invas
stage
iii
lymph
node
metastasi
stage
iv
distant
metastasi
welldifferenti
moder
poorli
differenti
addit
level
express
posit
correl
tumor
size
p
p
earlystag
iii
colorect
carcinoma
latestag
iiiiv
colorect
carcinoma
respect
tabl
appar
correl
express
clinic
factor
observ
tabl
analys
indic
upregul
colorect
cancer
cell
correl
tumor
progress
patient
earlystag
iii
colorect
carcinoma
divid
tumor
group
n
tumor
group
n
analysi
kaplanmei
method
reveal
signific
decreas
diseasefre
surviv
high
patient
compar
low
patient
v
logrank
p
figur
univari
analysi
express
number
lymph
node
tumor
size
significantli
correl
diseas
recurr
tabl
determin
whether
prognost
valu
express
independ
risk
factor
associ
clinic
outcom
colorect
carcinoma
multivari
analysi
perform
use
cox
proport
hazard
model
result
show
remain
prognost
factor
diseasefre
surviv
earlystag
colorect
carcinoma
patient
risk
ratio
ci
p
tabl
among
ajcc
stage
ii
crc
patient
high
express
found
sampl
express
rel
low
sampl
tumor
highli
express
also
show
significantli
poorer
diseasefre
surviv
logrank
p
figur
level
express
primari
colorect
carcinoma
specimen
latestag
iiiiv
colorect
carcinoma
patient
stratifi
tumor
highand
tumor
overal
surviv
analysi
colorect
cancer
patient
indic
level
express
invers
correl
surviv
time
patient
surgeri
patient
strong
express
show
significantli
decreas
overal
surviv
overal
surviv
curv
construct
kaplan
figur
level
express
significantli
correl
tnm
stage
histodifferenti
strong
immunoreact
like
present
latestag
crc
compar
earlystag
crc
p
bar
b
poorli
differenti
colorect
tumor
show
stronger
immunoreact
moder
well
differenti
colorect
tumor
p
bar
c
comparison
immunohistochem
score
accord
tnm
stage
c
histodifferenti
meier
method
analyz
use
logrank
test
logrank
p
figur
determin
prognost
signific
predictor
overal
surviv
patient
latestag
colorect
carcinoma
univari
multivari
analys
conduct
univari
analysi
clinic
factor
includ
age
lymph
node
metastasi
express
significantli
correl
overal
surviv
tabl
factor
signific
univari
analysi
show
trend
toward
signific
includ
multivari
model
result
show
express
could
use
prognost
factor
overal
surviv
colorect
carcinoma
patient
risk
ratio
ci
p
tabl
patient
stage
iii
crc
divid
tumor
group
n
tumor
group
n
univari
analysi
express
low
express
v
high
express
remain
significantli
differ
stage
iii
crc
patient
logrank
p
figur
explor
whether
correl
prolifer
colorect
cancer
cell
level
marker
cell
prolifer
analyz
resect
colorect
cancer
specimen
also
examin
antibodi
figur
level
plot
statist
analysi
use
spearman
correl
test
show
signific
correl
paramet
p
figur
result
suggest
might
play
causal
role
induct
prolifer
colorect
cancer
explor
effect
colorect
cancer
cell
prolifer
investig
express
level
mrna
protein
four
differ
colorect
cancer
cell
line
rko
lovo
figur
result
show
low
level
endogen
express
thu
human
cdna
transfect
cell
line
allow
format
coloni
two
clone
clone
clone
elev
select
studi
semiquantit
rtpcr
western
blot
confirm
stabli
overexpress
compar
mock
control
figur
mtt
assay
brdu
incorpor
assay
indic
two
subclon
grew
significantli
faster
control
cell
figur
f
perform
coloni
format
assay
plate
expect
result
show
two
subclon
yield
increas
coloni
compar
control
cell
figur
addit
treatment
protein
could
promot
cell
prolifer
addit
file
figur
c
shrnamedi
inhibit
express
cell
caus
signific
decreas
cell
prolifer
figur
collect
data
identifi
previous
unrecogn
growthstimulatori
effect
colorect
cancer
cell
analyz
level
express
colorect
carcinoma
tissu
immunohistochemistri
found
interest
phenomenon
number
carcinoma
cell
increas
carcinoma
cell
invad
deepli
tumor
region
close
invas
front
show
stronger
immunoreact
furthermor
major
cancer
cell
lymph
node
metastas
also
figur
phenomena
suggest
involv
crc
invas
metastasi
sever
vitro
studi
figur
effect
express
human
colorect
cancer
cell
prolifer
immunohistochem
stain
human
colorect
tumor
section
use
antibodi
bar
b
correl
express
level
n
p
twotail
spearman
test
coeffici
c
endogen
mrna
protein
level
determin
semiquantit
rtpcr
western
blot
sever
colorect
cancer
cell
line
stabli
overexpress
subclon
clone
clone
eg
prolifer
cell
stabli
express
mock
vector
compar
brdu
incorpor
assay
e
mtt
assay
f
coloni
format
assay
g
respect
h
express
cell
inhibit
transfect
ik
prolifer
cell
transfect
shnc
measur
brdu
assay
mtt
assay
j
coloni
format
assay
k
respect
error
bar
repres
sd
student
test
use
statist
analys
p
p
perform
obtain
valid
subclon
clone
clone
migrat
faster
control
cell
uncoat
membran
modifi
boyden
chamber
assay
invas
control
cell
demonstr
martrigel
invas
number
migrat
cell
group
clone
clone
respect
meanwhil
number
migrat
cell
mock
vectortransfect
cell
induc
cell
invas
threefold
compar
control
group
clone
clone
versu
mock
control
figur
addit
treatment
protein
also
acceler
cell
migrat
invas
addit
file
figur
e
howev
shrnamedi
inhibit
express
cell
caus
signific
decreas
cell
migrat
invas
figur
result
demonstr
function
potenti
promot
colorect
cancer
cell
migrat
invas
novel
nonelr
chemokin
yet
uncharacteris
receptor
report
associ
figur
promot
migrat
invas
cell
deepli
invad
carcinoma
cell
intens
stain
mucos
region
c
muscl
refer
circular
muscl
l
muscl
refer
longitudin
muscl
cancer
cell
lymph
node
metastas
also
bd
assay
use
evalu
migrationinvas
abil
subclon
overexpress
significantli
increas
migrat
invas
abil
number
migrat
c
invad
cell
five
random
field
count
present
cell
number
eg
motil
transfect
shnc
compar
transwel
assay
f
matrigel
assay
g
respect
column
mean
bar
se
triplic
student
test
use
statist
analys
p
p
tumor
progress
metastasi
studi
found
frequent
upregul
colorect
tumor
compar
adjac
normal
colorect
mucosa
find
consist
previou
studi
express
elev
tumor
tissu
compar
adjac
normal
tissu
best
knowledg
first
studi
analyz
express
protein
colorect
carcinoma
immunohistochemistri
use
surgic
resect
neoplast
tissu
furthermor
earli
stage
colorect
cancer
express
upregul
compar
adjac
normal
mucosa
suggest
overexpress
earli
event
develop
crc
intrigu
specul
possibl
reason
high
express
level
tumorigenesi
immunohistochem
analysi
show
express
mainli
locat
malign
colorect
epitheli
cell
partial
stroma
cell
henc
could
postul
similar
chemokin
like
signal
gcoupl
receptor
contribut
progress
crc
via
autocrin
paracrin
pathway
addit
level
express
significantli
associ
clinicopatholog
factor
includ
tnm
stage
histodifferenti
tumor
size
previou
studi
report
factor
possibl
predictor
earli
recurr
cancerdeath
among
tnm
stage
strongest
predictor
surviv
patient
colorect
cancer
correl
express
factor
impli
elev
express
may
associ
poor
patient
outcom
multivari
analysi
show
elev
level
patient
stage
iii
colorect
carcinoma
independ
risk
factor
develop
recurr
level
express
patient
stage
iiiiv
colorect
carcinoma
invers
correl
durat
surviv
therefor
use
prognost
factor
predict
outcom
patient
crc
surgic
resect
tumor
therefor
patient
colorect
carcinoma
show
elev
express
care
followedup
low
express
avoid
overtr
addit
tumor
high
express
wors
prognosi
even
within
clinicopatholog
stage
stage
system
base
extent
tumor
spread
time
primari
surgic
treatment
alway
account
aggress
tumor
clinic
perspect
abil
predict
outcom
within
clinicopatholog
stage
key
individu
treatment
option
degre
help
make
fact
tnm
stage
per
se
predict
outcom
patient
clinic
stage
although
clinicopatholog
data
deal
express
protein
level
current
scarc
increas
attent
paid
prognost
signific
diseas
use
antibodi
array
identifi
potenti
diagnost
marker
hepatocellular
carcinoma
addit
suggest
poor
prognost
marker
papillari
thyroid
carcinoma
qpcr
analysi
function
role
tumor
biolog
address
previou
report
present
studi
immunohistochem
analys
number
vitro
studi
perform
valid
aggress
role
colorect
cancer
progress
observ
good
correl
level
human
colorect
cancer
suggest
involv
human
colorect
cancer
cell
prolifer
inde
found
enhanc
malign
colorect
cell
prolifer
vitro
consist
find
cafderiv
report
exert
paracrin
stimulatori
effect
prolifer
prostat
cancer
cell
line
lncap
meanwhil
shown
enhanc
prolifer
breast
cancer
cell
accompani
robust
increas
erk
phosphoryl
autocrin
manner
intriguingli
express
observ
restrict
myoepitheli
cell
ductal
carcinoma
situ
tumor
epitheli
cell
invas
breast
carcinoma
suggest
might
convert
autocrin
factor
paracrin
factor
almost
specimen
studi
deepli
invad
cancer
cell
intens
stain
mucos
region
addit
number
cancer
cell
increas
cancer
cell
invad
deepli
cell
region
musculari
propria
subserosa
immunoposit
furthermor
almost
cancer
cell
lymph
node
metastas
also
result
suggest
may
involv
process
invas
metastasi
especi
lymphat
permeat
nodal
metastasi
colorect
cancer
cell
vitro
studi
valid
role
colorect
cancer
cell
migrat
invas
underli
mechan
colorect
cancer
cell
migrat
invas
clear
recent
report
show
activ
chemokin
signal
could
promot
tumor
cell
metastasi
regul
polymer
intracellular
actin
induc
format
pseudopodia
facilit
extracellular
matrix
degrad
remodel
find
consist
previou
studi
implic
alter
chemokin
express
level
indic
progress
tumorigenesi
metastasi
capac
howev
studi
report
potenti
colorect
carcinoma
initi
progress
contrast
previou
studi
report
defici
tumor
act
tumor
suppressor
recent
identifi
novel
potenti
cancerstimulatori
protein
result
obtain
present
studi
togeth
other
indic
need
analysi
possibl
tumor
typeand
stagespecif
effect
tumor
mechan
promot
inhibit
tumor
progress
need
analyz
seri
topic
worthi
studi
suggest
present
find
firstli
identif
receptor
pressingli
need
seed
soil
theori
target
organ
releas
specif
chemokin
attract
tumor
cell
bear
correspond
receptor
provid
accept
explan
mani
import
role
chemokin
receptor
cancer
metastasi
analys
effect
gpcr
inhibitor
known
target
profil
gpcr
profil
nonrespons
cell
possibl
use
receptor
identif
identif
factor
caus
upregul
tumor
epitheli
cell
anoth
relev
issu
warrant
analys
understand
mechan
chemokin
promot
cell
transform
tumor
progress
key
effect
therapi
examin
express
pattern
crc
clinic
valu
base
small
number
case
thu
requir
investig
clarifi
correl
express
clinic
outcom
crc
larger
patient
cohort
summari
result
provid
first
definit
immunohistochem
evid
express
upregul
colorect
cancer
addit
report
potenti
clinic
valu
understand
express
patient
crc
one
hand
could
use
prognost
factor
poor
diseas
outcom
hand
studi
suggest
express
may
benefici
individu
treatment
option
crc
patient
one
challeng
effect
therapi
lie
understand
mechan
chemokin
promot
cell
transform
tumor
progress
understand
mechan
essenti
develop
new
therapeut
strategi
effect
inhibit
cancer
growth
metastasi
taken
togeth
studi
form
basi
futur
potenti
novel
tumor
therapi
